| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
3 companies
Barry Richard is a Director at MDXG with holdings across 3 companies. Recent SEC Form 4 filings include 14 buys and 4 sells.
Estimated insider holdings value: $73.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | SAVA Cassava Sciences Inc | President &CEO | Buy | 150,000 | $2.76 | $414,000.00 | +19.0% | -19.0% | - | |
| Nov 19, 2025 | SAVA Cassava Sciences Inc | President &CEO | Buy | 73,385 | $2.75 | $201,808.75 | +10.3% | -24.0% | - | |
| Sep 22, 2025 | SAVA Cassava Sciences Inc | President &CEO | Buy | 7,172 | $2.28 | $16,352.16 | +1.0% | +2.6% | - | |
| Sep 19, 2025 | SAVA Cassava Sciences Inc | President &CEO | Buy | 237,941 | $2.25 | $534,743.24 | +10.5% | +25.0% | - | |
| Nov 3, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 50,000 | $78.81 | $3,940,500.00 | +50.0% | +57.5% | +58.0% | |
| Aug 22, 2023 | SAVA Cassava Sciences Inc | Director | Buy | 18,477 | $16.67 | $307,927.95 | +3.3% | +32.6% | +81.1% | |
| Mar 7, 2023 | SAVA Cassava Sciences Inc | Director | Buy | 88,841 | $25.81 | $2,292,823.21 | +23.1% | -9.2% | -21.3% | |
| Aug 23, 2022 | SAVA Cassava Sciences Inc | Director | Buy | 36,159 | $23.79 | $860,222.61 | +24.1% | +28.8% | -31.2% | |
| Aug 7, 2020 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 30,000 | $158.50 | $4,754,972.40 | -0.5% | - | - | |
| May 15, 2020 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 30,000 | $141.26 | $4,237,945.89 | -0.5% | - | - |